Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02873754 · ClinicalTrials.gov registry record · NA
Smoking Treatment and Exercise Program for Underserved Populations (STEP UP)
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT02873754: Completed NA study, sponsored by Duke University.
NCT02873754 is a NA study that has completed, run by Duke University. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02873754, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
This project proposes to evaluate the feasibility, acceptability, and efficacy of a mobile intervention to target smoking-cessation and increase physical activity among low-income persons. The intervention is called Smoking Treatment and Exercise Program for Underserved Populations (STEP UP).
Primary Outcome
Participants will be asked to report on smoking since two weeks past quit date. Prolonged abstinence is defined as continued abstinence from smoking beginning at 2 weeks post-quit.
Interventions
- DRUG Bupropion
- DRUG Transdermal nicotine patch
- DRUG Nicotine polacrilex
- BEHAVIORAL Cognitive Behavioral Counseling
- BEHAVIORAL Mobile Contingency Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2017-01 |
| Est. Completion | 2017-07 |
| Phase | NA |
What the finished NCT02873754 record still lists
NCT02873754 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 5 interventions - of which Bupropion is the first listed.
NCT02873754 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02873754 about?
NCT02873754 is a clinical study titled "Smoking Treatment and Exercise Program for Underserved Populations (STEP UP)". This project proposes to evaluate the feasibility, acceptability, and efficacy of a mobile intervention to target smoking-cessation and increase physical activity among low-income persons. The intervention is called Smoking Treatment and Exercise Program for Underserved Populations (STEP UP).
What is the current status of trial NCT02873754?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2017-01. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02873754?
The interventions under investigation include: Bupropion (DRUG), Transdermal nicotine patch (DRUG), Nicotine polacrilex (DRUG), Cognitive Behavioral Counseling (BEHAVIORAL), Mobile Contingency Management (BEHAVIORAL).
Who is sponsoring clinical trial NCT02873754?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02873754's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia